Share This Page
Patent: 11,459,595
✉ Email this page to a colleague
Summary for Patent: 11,459,595
Patent Claims: | see list of patent claims |
Patent landscape, scope, and claims summary: | Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 11,459,595 IntroductionPatents are a crucial component of intellectual property, providing exclusive rights to inventors and innovators. Understanding the claims and the broader patent landscape is essential for navigating the complex world of intellectual property. This article will delve into the specifics of United States Patent 11,459,595, analyzing its claims and positioning it within the current patent landscape. Understanding Patent ClaimsPatent claims are the heart of a patent, defining the scope of the invention and what is protected. They must be clear, concise, and specific to ensure that the patent holder's rights are well-defined and enforceable[2]. Types of Claims
The 2024 USPTO Guidance Update on AI PatentsRecent updates from the USPTO, particularly the 2024 guidance on AI patents, have significant implications for patent claims. The guidance emphasizes the importance of integrating abstract ideas into practical applications to ensure patent eligibility. This means that claims must demonstrate concrete technological improvements and real-world applications to avoid section 101 rejections[3]. Practical ApplicationsFor a claim to be patent-eligible, it must go beyond mere abstract ideas or routine data processing. It must specify how the invention is used in a practical application, providing tangible benefits. For example, a claim that uses separated audio components in a speech recognition system to enhance voice command accuracy is considered patent-eligible because it integrates the abstract idea into a practical application[3]. Valuation of PatentsUnderstanding the value of a patent is crucial for both inventors and investors. There are three primary methods for valuing patents: cost, income, and market approaches. Cost ApproachThis method considers the cost incurred to develop the patent, which includes research and development expenses, legal fees, and other associated costs. Since patents are unique and cannot be replicated, this approach focuses on the historical costs rather than replacement costs[1]. Income ApproachThis method evaluates the future benefits provided by the patent, such as royalties or cost savings. The income value is the present value of these benefits over the patent's lifetime[1]. Market ApproachThis method determines the patent's value based on what a willing buyer would pay for a similar asset. It involves analyzing sales and asking price data for comparable patents[1]. Trends in Patent ApplicationsThe number of patent applications has been increasing significantly over the years. From approximately 100,000 applications per year in the 1960s and 1980s to over 326,000 in 2001, this trend is driven by technological innovation and facilitated by advancements in technology such as word processing and remote electronic database searching[2]. Increasing ComplexityThe rise in patent applications has also led to an increase in the number of claims filed with each application. Some applications now include several hundred or even thousands of claims, complicating the process of reviewing and understanding patent property[2]. Advanced Patent Searching TechniquesGiven the complexity and volume of patent applications, advanced searching techniques are essential. These include using Cooperative Patent Classification (CPC) codes to categorize and filter patent applications, and leveraging tools to accelerate comprehensive searches and gain better patent insights[4]. CPC CodesCPC codes are used to categorize patent applications at both the subclass and subgroup levels. For example, in the field of hydrogen and fuel cell technologies, specific CPC codes like "Y02E 60/521" are used to capture relevant technologies and filter out irrelevant ones[5]. Case Study: United States Patent 11,459,595While the specific details of United States Patent 11,459,595 are not provided here, a comprehensive analysis would involve several key steps: Claim Analysis
Patent Landscape
Regulatory Compliance
Real-World Applications and BenefitsTo bolster the argument for patent eligibility, it is crucial to highlight the real-world applications and benefits of the invention. For example, if the patent relates to a technological improvement in speech recognition systems, demonstrating how it enhances accuracy in hands-free environments can significantly strengthen its case for patent eligibility[3]. Challenges and OpportunitiesThe increasing complexity of patent applications and the growing number of claims present both challenges and opportunities. Challenges
Opportunities
Key Takeaways
FAQsQ: What are the key components of a patent claim?A: The key components include independent and dependent claims, method and apparatus claims, and ensuring that the claims integrate abstract ideas into practical applications. Q: How does the 2024 USPTO guidance impact AI-related patents?A: The guidance emphasizes the need to integrate abstract ideas into practical applications and provides examples of patent-eligible and ineligible claims, helping practitioners draft claims that avoid section 101 rejections. Q: What are the primary methods for valuing patents?A: The primary methods are the cost approach, income approach, and market approach. Q: Why is using CPC codes important in patent searching?A: CPC codes help categorize and filter patent applications, making it easier to identify relevant technologies and navigate the complex patent landscape. Q: What is the significance of demonstrating real-world applications in patent claims?A: Demonstrating real-world applications helps to ensure that the claims meet the criteria for patent eligibility by showing concrete technological improvements and tangible benefits. Sources
More… ↓ |
Details for Patent 11,459,595
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen Inc. | PROLIA | denosumab | Injection | 125320 | June 01, 2010 | ⤷ Subscribe | |
Amgen Inc. | XGEVA | denosumab | Injection | 125320 | November 18, 2010 | ⤷ Subscribe | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |